BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30908904)

  • 21. Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids.
    Chen AL; Janko E; Pitman MB; Chebib I
    Cancer Cytopathol; 2019 Dec; 127(12):778-784. PubMed ID: 31693303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.
    Chirieac LR; Pinkus GS; Pinkus JL; Godleski J; Sugarbaker DJ; Corson JM
    Am J Cancer Res; 2011; 1(1):14-24. PubMed ID: 21969119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Rivera MP; Mehta AC; Wahidi MM
    Chest; 2013 May; 143(5 Suppl):e142S-e165S. PubMed ID: 23649436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
    Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
    Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification.
    Weissferdt A; Kalhor N; Correa AM; Moran CA
    Hum Pathol; 2017 May; 63():14-26. PubMed ID: 27993578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic features of sarcomatoid carcinoma of the urinary bladder: a case report.
    Iwa N; Ito S; Takegaki Y; Ikura Y; Kobayashi TK; Yasukawa S; Kobayashi Y
    Diagn Cytopathol; 2013 Jun; 41(6):536-41. PubMed ID: 21953942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary mediastinal histiocytic sarcoma presenting as pleural effusion.
    Jhuang JY; Chen WY; Chuang SS
    Diagn Cytopathol; 2018 Sep; 46(9):790-793. PubMed ID: 29756323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions.
    Dinu M; Ciurea RN; Stefan M; Georgescu AC
    Rom J Morphol Embryol; 2012; 53(3 Suppl):817-20. PubMed ID: 23188446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass.
    Logunova V; Sokumbi O; Iczkowski KA
    J Cutan Pathol; 2017 Oct; 44(10):874-877. PubMed ID: 28675457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A; Fanger G; Khan A; Rock KL; Xu B
    Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomatoid carcinoma of urinary bladder: immunohistochemical study of an uncommon case.
    Cappello F; Aragona F; Serretta V; Randazzo G; Melloni D
    Urol Int; 2002; 69(2):141-4. PubMed ID: 12187046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spindle Cell Sarcoma Presenting as Pancoast Syndrome.
    Badshah A; Khan S; Saeed U
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):623-5. PubMed ID: 27504558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effusion cytology of granulocytic sarcoma in an unusual clinical scenario: a diagnostic challenge.
    Singh G; Agarwal S; Iyer VK; Sharma A; Chopra A; Mathur SR
    Acta Cytol; 2012; 56(3):315-20. PubMed ID: 22555536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of pleural effusion: comparison between fibreoptic thoracoscopy, needle biopsy and cytology.
    Edmondstone WM
    Respir Med; 1990 Jan; 84(1):23-6. PubMed ID: 2371417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
    Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External quality assurance in nongynecologic cytology: The Australasian experience.
    Shield PW; Frost F; Finnimore JL; Wright RG; Cummings MC
    Cancer Cytopathol; 2017 May; 125(5):349-361. PubMed ID: 28241108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.